Testing effectiveness (Phase 2)Looking for participantsNCT06891885
What this trial is testing
Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa
Who this might be right for
Retinitis Pigmentosa
Sumitomo Pharma America, Inc. 12